CompletedNot Applicable

Early Ventriculo-peritoneal Shunt in Subarachnoid Patients With External Ventricular Drainage

Iran100 participantsStarted 2017-01

Plain-language summary

Acute hydrocephalus is a common complication following subarachnoid hemorrhage (SAH). Early and emergency insertion of external ventricular drain (EVD) is standard treatment of acute post-SAH hydrocephalus. According to the high risk of infection associated with EVD, the study evaluates the outcome of early EVD conversion to ventriculoperitoneal shunt (VPS) in poor-grade SAH patients.

Who can participate

Age range

18 Years – 90 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patients with SAH and World Federation of Neurosurgeon (WFNS) Grade 4 or 5 and * patient who underwent ventriculostomy (EVD insertion) within 24 hours of SAH onset. Exclusion Criteria: * patients with Glasgow Coma Scale of (GCS) 3 and fixed non-reactive pupils, * patients in whom EVD was inserted in the other hospital, * patients were successfully weaned from EVD with 7-10 days of EVD insertion * patients who died during hospitalization.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

rate of ventriculo-peritoneal malfunction

Timeframe: 3 months

rate of ventricle-peritoneal infection

Timeframe: 3 months

Trial details

NCT IDNCT04567277

SponsorMashhad University of Medical Sciences

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-02

View on ClinicalTrials.gov More Subarachnoid Hemorrhage trials